ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
Globe Newswire•27/10/2026•02:30 ET
0
Key Highlights
- ➤Q3 2026 results scheduled for release November 3, 2026
- ➤Webcast with comprehensive business update begins at 2:00 p.m. CET
- ➤ARC-EX System cleared for commercial sale in US and Europe
- ➤ARC-IM implantable system remains investigational and unavailable commercially
Expert Statements
Dave Marver, CEO of ONWARD Medical
“Dave Marver”
EINDHOVEN, The Netherlands, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its third-quarter 2026 financial results and host a webcast with a comprehensive business update on November 3, 2026.
The webcast, presented by CEO Dave Marver, will begin at 2:00 p.m. CET / 8:00 a.m. ET. To join, please register using this link. A replay of the webcast and supporting materials will be available at ir.onwd.com.
Get started
Create a free account to read the full story.